The Bundibugyo Ebola outbreak in DRC, a PHEIC since May, has reached 9,277 confirmed cases and 4,478 deaths. North Ubangi is now the eighth affected province, and only 78% of contacts are being followed up. Kenya has eight cases linked to an imported index case, including three health workers, but no evidence of community transmission. Measles risk in the Americas is very high, with 55,792 cases and 77 deaths across 17 countries, mostly in Guatemala and Mexico. US transmission is rising, with 4,410 cases this year, nearly double the 2025 total. Dengue is surging widely: Chad has 213 confirmed cases and 7 deaths, Ecuador has exceeded its 2025 total amid a shift to DENV-3, Florida has 368 local cases and Italy 70. Europe’s record West Nile season (1,926 cases) is spreading north, with 59 Dutch cases and Belgium’s first local infections and deaths. Côte d’Ivoire reports 23 yellow fever cases and 11 deaths.
Ebola disease outbreak cause by Bundibugo virus, D.R. Congo
The Ebola outbreak in DRC, caused by Bundibugyo virus (BDBV), was declared on 15 May 2026 and has been a PHEIC since 17 May. As of 15 October, DRC reported 9,277 confirmed cases and 4,478 deaths, with 65 new cases on 14 October alone. Ituri (6,806 cases) and North Kivu (1,991) are worst affected. In total, 65 of 167 health zones across seven provinces are involved, and only 78% of contacts are under follow-up. Two cases have been confirmed in North Ubangi, on the border with the Central African Republic, making it the eighth affected province. Kenya’s index patient, a Kenyan living in DRC, arrived via Uganda on 3 October and died two days later. By 17 October, Kenya had seven confirmed cases, including three health workers who treated the first patient. All new cases were already in quarantine when symptoms began. The ministry reports 128 of 130 contacts quarantined and no evidence of community transmission. On 18 October, an eighth case was confirmed: a 49-year-old man, not a health worker.
Measles, Americas
PAHO’s 8 October 2026 assessment rates the regional measles risk in the Americas as very high. From 4 January to 3 October, 17 countries reported 55,792 confirmed cases and 77 deaths, 4.8 times the comparable 2025 period. Guatemala (34,355), Mexico (13,595), the US (3,887), Peru (2,553) and Canada (1,121) account for 99.5% of cases, all with community transmission. Most deaths occurred in Guatemala (50) and Mexico (23). In Guatemala, the mortality rate among infants was 17 times the overall rate. Regional MMR coverage in 2025 was 88% for the first dose and 85% for the second, and 1.6 million children went unvaccinated. Modelling shows transmission declining in Guatemala and Mexico but rising in the US. More recent US national data show 4,410 confirmed cases in 2026, nearly double the 2,289 for all of 2025. Cases span 47 jurisdictions and 42 new outbreaks, and 96% are outbreak-associated. Two deaths are provisionally reported, although Pennsylvania reports five measles-associated deaths, three still under review. Cases have risen from 59 (2023) to 285 (2024), 2,289 (2025) and 4,410 so far.
Dengue, global updates
As of 8 October, 2,929 suspected dengue cases have been reported in Chad, of which 213 were PCR-confirmed, with 7 deaths. N’Djamena accounts for 173 confirmed cases (81%). In Sudan, 927 cases were registered North Darfur, between September and 16 October. Ecuador reported 38,607 cases as of 3 October (211.62 per 100,000), already 2% above the 2025 full-year total, with DENV-3 now predominating, replacing the DENV-2 dominance of 2024–2025. Florida reported 368 locally acquired cases as of 10 October, compared with 62 in all of 2025. Most were in Hillsborough (310) and Pinellas (37), and nearly all were DENV-2.In Europe, Italy has 70 locally acquired cases in seven active clusters, including a new one in Rome.
West Nile virus, Europe and USA
Europe is experiencing its most intense West Nile virus (WNV) season on record. As of 7 October 2026, EU countries reported 1,715 locally acquired human cases and 130 deaths. By 14 October, ECDC counted 1,926 autochthonous cases across 19 European countries. Italy is most affected (748 cases), and Greece and France recorded national highs. The virus is moving north. The Netherlands has reported 59 human cases and Belgium 15, its first locally acquired infections ever. On 15 October, Flanders reported two deaths among 14 confirmed infections, both in patients at high risk of severe disease. Local circulation there had been ongoing for months. In the US, 1,328 cases (76% neuroinvasive) have been reported in 2026
Yellow fever, Côte d'Ivoire
As of 15 October 2026, 23 yellow fever cases and 11 deaths have been reported in Boukani, located in northeastern Côte d'Ivoire. A request for information has been issued to obtain further details regarding diagnostic testing and the epidemiological investigation.
10,676 confirmed cases and 31 deaths reported in Mato Grosso do Sul in 2026.
Epidemic declared across four provinces with 2929 suspected cases, 213 confirmed, and 7 deaths.
38 607 cases reported in 2026, an 11.57% increase, with DENV-3 predominating.
More than 900 cases registered in Tawila amid medicine shortages and poor healthcare infrastructure.
368 autochthonous cases and one related death reported in Florida; local emergencies extended.
15 confirmed cases reported, mostly in Casablanca-Settat and Souss-Massa, with two deaths under investigation.
161 confirmed cases and 11 deaths reported across 12 medical regions since July 2026.
55,792 cases and 77 deaths reported; risk assessed as very high before mass gatherings.
3659 confirmed cases reported nationwide, with six associated deaths in Pennsylvania and widespread outbreaks.
23 cases and 11 deaths reported in Boukani; diagnostic and epidemiological information requested.
14 confirmed cases and first two deaths reported in the Flanders region.
First human H5N5 fatality in Washington and documented cat-to-human H5N1 transmission in California.
Sharp increase in diagnoses across southeastern regions, with first cases confirmed on Cape Cod.
1,328 human West Nile cases across 45 states so far in 2026, 1,004 (76%) neuroinvasive
Multiple sporadic human A(H9N2) infections and one fatal A(H5N6) case linked to poultry exposure
Human infection with Dracunculus species reported with spring-water exposure; species identification remains incomplete.
7,784 cases reported in 2026, with culture-confirmed cases in Hadramout and alerts in Aden.
Eight laboratory-confirmed cases and one death reported across six locations since January 2026.
Over 39,483 cases reported in 2026, with elevated fatality rates in non-endemic western zones.
Outbreak extends to North Ubangi province, recording two confirmed cases and suspected deaths.
Seven confirmed cases, including three healthcare workers, linked to an imported fatal index case.
One new confirmed case in a 49-year-old man brings the national total to eight.
Outbreak alert in Beliel with 273 suspected cases, including 78 currently active cases.
1,138 confirmed cases and 268 deaths reported across 24 states in 2026.
Three pneumonic cases and additional suspected bubonic cases reported in South Midongy state.
The ESCMID-AUMC Epi Alert, a strategic collaboration between the ESCMID Emerging Infections Subcommittee and the Center of Tropical Medicine and Travel Medicine of Amsterdam University Medical Center (AUMC) that integrates expertise and resources to advance emerging infectious diseases surveillance and intelligence sharing. This collaboration integrates ESCMID's extensive international network and emerging infections expertise with AUMC's proven surveillance capabilities, led by Dr. Abraham Goorhuis and the AUMC team and other collaborators form European Institutions.
The Epi Alert aims to be a weekly publication. The briefings are curated by infectious disease specialists prioritising data from trusted sources (such as Beacon, H-Radar, Outbreaknews, WHO, ECDC, CDC) based on potential impact, geographic region and urgency/relevancy to clinical practice. It aims to provide concise summaries for busy healthcare professionals with direct links for further investigation and transparency.
This integrated collaboration represents a significant milestone in ESCMID's commitment to emerging infections preparedness, strengthening our collective capacity to detect, analyse, and respond to infectious disease threats through international cooperation.
Disclaimer: The information in this epi-alert is a weekly summary of the information that is available on the internet, mainly the websites of Beacon, H-Radar, Outbreaknews, WHO, ECDC, CDC, and others. For this summary, we consider issues that are most relevant to the ESCMID members involved in clinical patient care. Therefore, this report is not comprehensive, but we strive to include all major global issues in this report on a weekly basis.